Superior survival of unmanipulated haploidentical hematopoietic stem cell transplantation compared with chemotherapy alone used as post-remission therapy in adults with standard-risk acute lymphoblastic leukemia in first complete remission

Biology of Blood and Marrow Transplantation

Volumn 20, Issue 9, 2014, Pages 1314-1321

  Yan, Chen Hua ^a   Jiang, Qian ^a   Wang, Jing ^a   Xu, Lan Ping ^a   Liu, Dai Hong ^a   Jiang, Hao ^a   Chen, Huan ^a   Zhang, Xiao hui ^a   Liu, Kai yan ^a   Huang, Xiao Jun ^a  

^a PEKING UNIVERSITY PEOPLE S HOSPITAL   (China)

Author keywords

Acute lymphoblastic leukemia; Chemotherapy; Haploidentical; Hematopoietic stem cell transplantation; Standard risk

Indexed keywords

ACUTE DISEASE; ADOLESCENT; ADULT; DISEASE FREE SURVIVAL; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; MALE; MIDDLE AGED; MORTALITY; PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; PROCEDURES; RISK FACTOR; SURVIVAL; YOUNG ADULT;

ACUTE DISEASE; ADOLESCENT; ADULT; DISEASE-FREE SURVIVAL; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; MALE; MIDDLE AGED; PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; RISK FACTORS; SURVIVAL ANALYSIS; TRANSPLANTATION CONDITIONING; YOUNG ADULT;

EID: 84905573341     PISSN: 10838791     EISSN: 15236536     Source Type: Journal    
DOI: 10.1016/j.bbmt.2014.04.011     Document Type: Article

References (30)

1. Gökbuget N., Kneba M., Raff T., et al. Adult patients with acute lymphoblastic leukemia and molecular failure display a poor prognosis and are candidates for stem cell transplantation and targeted therapies. Blood 2012, 120:1868-1876.
2. Gökbuget N., Hoelzer D. Treatment of adult acute lymphoblastic leukemia. Semin Hematol 2009, 46:64-75.
3. Fière D., Lepage E., Sebban C., et al. Adult acute lymphoblastic leukemia: a multicentric randomized trial testing bone marrow transplantation as postremission therapy. The French Group on Therapy for Adult Acute Lymphoblastic Leukemia. JClin Oncol 1993, 11:1990-2001.
4. Thiebaut A., Vernant J.P., Degos L., et al. Adult acute lymphocytic leukemia study testing chemotherapy and autologous and allogeneic transplantation. A follow-up report of the French protocol LALA-87. Hem/Oncol Clin North Am 2000, 14:1353-1365.
5. Thomas X., Boiron J.M., Huguet F., et al. Outcome of treatment in adults with acute lymphoblastic leukemia: analysis of the LALA-94 trial. JClin Oncol 2004, 22:4075-4086.
6. Fielding A.K., Richards S.M., Chopra R., et al. Outcome of 609 adults after relapse of acute lymphoblastic leukemia (ALL); an MRC UKALL12/ECOG 2993 study. Blood 2007, 109:944-950.
7. Goldstone A.H., Richards S.M., Lazarus H.M., et al. In adults with standard-risk acute lymphoblastic leukemia, the greatest benefit is achieved from a matched sibling allogeneic transplantation in first complete remission, and an autologous transplantation is less effective than conventional consolidation/maintenance chemotherapy in all patients: final results of the International ALL Trial (MRC UKALL XII/ECOG E2993). Blood 2008, 111:1827-1833.
8. Cornelissen J.J., van der Holt B., Verhoef G.E., et al. Myeloablative allogeneic versus autologous stem cell transplantation in adult patients with acute lymphoblastic leukemia in first remission: a prospective sibling donor versus no-donor comparison. Blood 2009, 113:1375-1382.
9. Lu D.P., Dong L., Wu T., et al. Conditioning including antithymocyte globulin followed by unmanipulated HLA-mismatched/haploidentical blood and marrow transplantation can achieve comparable outcomeswith HLA-identical sibling transplantation. Blood 2006, 107:3065-3073.
10. Wang Y., Liu D.H., Liu K.Y., et al. Long-term follow-up of haploidentical hematopoietic stem cell transplantation without invitro T cell depletion for the treatment of leukemia: nine years of experience at a single center. Cancer 2013, 119:978-985.
11. Ciceri F., Labopin M., Aversa F., et al. Asurvey of fully haploidentical hematopoietic stem cell transplantation in adults with high-risk acute leukemia: a risk factor analysis of outcomes for patients in remission at transplantation. Blood 2008, 112:3574-3581.
12. Federmann B., Bornhauser M., Meisner C., et al. Haploidentical allogeneic hematopoietic cell transplantation in adults using CD3/CD19 depletion and reduced intensity conditioning: an update. Blood Cell Mol Dis 2008, 40:13-19.
13. Luznik L., O'Donnell P.V., Symons H.J., et al. HLA-haploidentical bone marrow transplantation for hematologic malignancies using nonmyeloablative conditioning and high-dose, posttransplantation cyclophosphamide. Biol Blood Marrow Transplant 2008, 14:641-650.
14. Yan C.H., Liu D.H., Liu K.Y., et al. Risk stratification-directed donor lymphocyte infusion could reduce relapse of standard-risk acute leukemia patients after allogeneic hematopoietic stem cell transplantation. Blood 2012, 119:3256-3262.
15. Yan C.H., Wang J.Z., Liu D.H., et al. Chemotherapy followed by modified donor lymphocyte infusion as a treatment for relapsed acute leukemia after haploidentical hematopoietic stem cell transplantation without invitro T-cell depletion: superior outcomes compared with chemotherapy alone and an analysis of prognostic factors. Eur J Haematol 2013, 91:304-314.
16. Zhao X.S., Liu Y.R., Zhu H.H., et al. Monitoring MRD with flow cytometry: an effective method to predict relapse for ALL patients after allogeneic hematopoietic stem cell transplantation. Ann Hematol 2012, 91:183-192.
17. Zhao X.S., Jin S., Zhu H.H., et al. Wilms' tumor gene 1 expression: an independent acute leukemia prognostic indicator following allogeneic hematopoietic SCT. Bone Marrow Transplant 2012, 47:499-507.
18. Mastrangelo R., Poplack D., Bleyer A., et al. Report and recommendations of the Rome workshop concerning poor-prognosis acute lymphoblastic leukemia in children: biologic bases for staging, stratification, and treatment. Med Pediatr Oncol 1986, 14:191-194.
19. Mahmoud H.H., Rivera G.K., Hancock M.L., et al. Low leukocyte counts with blast cells in cerebrospinal fluid of children with newly diagnosed acute lymphoblastic leukemia. NEngl J Med 1993, 329:314-319.
20. Faderl S., Kantarjian H.M., Talpaz M., Estrov Z. Clinical significance of cytogenetic abnormalities in adult acute lymphoblastic leukemia. Blood 1998, 91:3995-4019.
21. Moorman A.V., Harrison C.J., Buck G.A., et al. Karyotype is an independent prognostic factor in adult acute lymphoblastic leukemia (ALL): analysis of cytogenetic data from patients treated on the Medical Research Council (MRC) UKALLXII/Eastern Cooperative Oncology Group (ECOG) 2993 trial. Blood 2007, 109:3189-3197.
22. Wetzler M., Dodge R.K., Mrózek K., et al. Prospective karyotype analysis in adult acute lymphoblastic leukemia: the cancer and leukemia Group B experience. Blood 1999, 93:3983-3993.
23. Charrin C., Thomas X., Ffrench M., et al. Areport from the LALA-94 and LALA-SA groups on hypodiploidy with 30 to 39 chromosomes and near-triploidy: 2 possible expressions of a sole entity conferring poor prognosis in adult acute lymphoblastic leukemia (ALL). Blood 2004, 104:2444-2451.
24. Scrucca L., Santucci A., Aversa F. Regression modeling of competing risk using R: an in depth guide for clinicians. Bone Marrow Transplant 2010, 45:1388-1395.
25. Efron B. Logistic regression, survival analysis and the Kaplan-Meier curve. JAm Stat Assoc 1988, 83:414-425.
26. Ram R., Gafter-Gvili A., Vidal L., et al. Management of adult patients with acute lymphoblastic leukemia in first complete remission: systematic review and meta-analysis. Cancer 2010, 116:3447-3457.
27. Pidala J., Djulbegovic B., Anasetti C., et al. Allogeneic hematopoietic cell transplantation for adult acute lymphoblastic leukemia (ALL) in first complete remission. Cochrane Database Syst Rev 2011, (10):CD008818.
28. Wang Y., Liu D.H., Xu L.P., et al. Superior graft-versus-leukemia effect associated with transplantation of haploidentical compared with HLA-identical sibling donor grafts for high-risk acute leukemia: an historic comparison. Biol Blood Marrow Transplant 2011, 17:821-830.
29. Garand R., Beldjord K., Cavé H., et al. Flow cytometry and IG/TCR quantitative PCR for minimal residual disease quantitation in acute lymphoblastic leukemia: a French multicenter prospective study on behalf of the FRALLE, EORTC and GRAALL. Leukemia 2013, 27:370-376.
30. Hu S.Y., Gu W.Y., Chen Z.X., et al. The significance of detecting WT1 expression in childhood acute leukemias. Pediatr Hematol Oncol 2010, 27:581-591.